These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26991810)

  • 1. Evaluation of Fibrosis Markers: Apelin and Transforming Growth Factor-β1 in Autosomal Dominant Polycystic Kidney Disease Patients.
    Kocer D; Karakukcu C; Ozturk F; Eroglu E; Kocyigit I
    Ther Apher Dial; 2016 Oct; 20(5):517-522. PubMed ID: 26991810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Fas Ligand, Serum Myostatin and Urine TGF-β1 Are Elevated in Autosomal Dominant Polycystic Kidney Disease Patients with Impaired and Preserved Renal Function.
    Raptis V; Bakogiannis C; Loutradis C; Boutou AK; Sioulis A; Balaskas E; Zebekakis P; Sarafidis PA
    Kidney Blood Press Res; 2018; 43(3):744-754. PubMed ID: 29794429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apelin and copeptin: two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease.
    Lacquaniti A; Chirico V; Lupica R; Buemi A; Loddo S; Caccamo C; Salis P; Bertani T; Buemi M
    Peptides; 2013 Nov; 49():1-8. PubMed ID: 23973863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No association of the TGF-beta1 gene polymorphisms with the renal progression in autosomal dominant polycystic kidney disease (ADPKD) patients.
    Lee JG; Ahn C; Yoon SC; Park JH; Eo HS; No JJ; Kim KH; Lee EJ; Hwang YH; Hwang DY; Kim YS; Han JS; Kim S; Lee JS; Kim SH
    Clin Nephrol; 2003 Jan; 59(1):10-6. PubMed ID: 12572925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of urinary endothelin-1 with estimated glomerular filtration rate in autosomal dominant polycystic kidney disease: a pilot cross-sectional analysis.
    Raina R; Lou L; Berger B; Vogt B; Do AS; Cunningham R; Vasavada P; Herrmann K; Dell K; Simonson M
    BMC Nephrol; 2016 Feb; 17():22. PubMed ID: 26923419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystatin C estimated glomerular filtration rate to assess renal function in early stages of autosomal dominant polycystic kidney disease.
    Sans L; Radosevic A; Quintian C; Montañés R; Gràcia S; Vilaplana C; Mojal S; Ballarin JA; Fernández-Llama P; Torra R; Pascual J
    PLoS One; 2017; 12(3):e0174583. PubMed ID: 28346513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of TGF-β1 induces renal fibrosis and accelerates the decline in kidney function in polycystic kidney disease.
    Zhang Y; Dai Y; Raman A; Daniel E; Metcalf J; Reif G; Pierucci-Alves F; Wallace DP
    Am J Physiol Renal Physiol; 2020 Dec; 319(6):F1135-F1148. PubMed ID: 33166182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulatory peptide apelin: a novel inhibitor of renal interstitial fibrosis.
    Wang LY; Diao ZL; Zhang DL; Zheng JF; Zhang QD; Ding JX; Liu WH
    Amino Acids; 2014 Dec; 46(12):2693-704. PubMed ID: 25164121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-beta mediated epithelial-mesenchymal transition in autosomal dominant polycystic kidney disease.
    Chea SW; Lee KB
    Yonsei Med J; 2009 Feb; 50(1):105-11. PubMed ID: 19259356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coregulation Analysis of Mechanistic Biomarkers in Autosomal Dominant Polycystic Kidney Disease.
    Leierer J; Perco P; Hofer B; Eder S; Dzien A; Kerschbaum J; Rudnicki M; Mayer G
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mean platelet volume and its relation with arterial stiffness in patients with normotensive polycystic kidney disease.
    Orscelik O; Kocyigit I; Akpek M; Dogdu O; Kaya C; Unal A; Sipahioglu M; Tokgoz B; Zengin H; Oymak O; Kaya MG
    J Investig Med; 2013 Mar; 61(3):597-603. PubMed ID: 23360844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
    Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
    Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of Endocan, Angiopoietin-2, and Hypoxia-Inducible Factor-1a in Patients with Autosomal Dominant Polycystic Kidney Disease and Different Levels of Renal Function.
    Raptis V; Bakogiannis C; Loutradis C; Boutou AK; Lampropoulou I; Intzevidou E; Sioulis A; Balaskas E; Sarafidis PA
    Am J Nephrol; 2018; 47(4):231-238. PubMed ID: 29597186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
    Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
    BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Copeptin levels and kidney function in ADPKD: case-control study.
    Corradi V; Martino F; Gastaldon F; Scalzotto E; Caprara C; Fortunato A; Pinaffo G; Marchetti C; Fabbi F; Giavarina D; Ferrari F; Rosner MH; Ronco C
    Clin Nephrol; 2016 Sep; 86(9):147-53. PubMed ID: 27487355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased urine transforming growth factor β1 (TGF-β1) and serum uric acid are associated with an early decline of glomerular filtration rate in kidney transplant recipients.
    Sibunruang C; Ingsathit A; Kantachuvesiri P; Radinahamed P; Rattanasiri S; Pootracool P; Kijvikai K; Sumethkul V; Kantachuvesiri S
    Transplant Proc; 2015 Mar; 47(2):304-8. PubMed ID: 25769564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of apelin‑13 and its negative correlation with TGF‑β1 in patients with diabetic kidney disease.
    Wang Q; Liu X; Zhai A; Xu H; Ma S; Liu Y
    Exp Ther Med; 2024 Mar; 27(3):110. PubMed ID: 38361517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The natural history of autosomal dominant polycystic kidney disease: 30-year experience from a single centre.
    Thong KM; Ong AC
    QJM; 2013 Jul; 106(7):639-46. PubMed ID: 23587574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte Injury in Autosomal Dominant Polycystic Kidney Disease.
    Cebeci E; Ekinci I; Gursu M; Coskun C; Karadag S; Uzun S; Behlul A; Senel TE; Kazancioglu R; Ozturk S
    Nephron; 2019; 142(4):311-319. PubMed ID: 31117091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients.
    Kocyigit I; Kaya MG; Orscelik O; Kaya C; Akpek M; Zengin H; Sipahioglu MH; Unal A; Yilmaz MI; Tokgoz B; Oymak O; Axelsson J
    Am J Nephrol; 2012; 36(1):11-8. PubMed ID: 22699414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.